ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0846

Three Novel Metabolomic Signatures of Inflammation for Female Gout Risk: A Prospective Cohort Study over 26 Years

Sharan Rai1, Hyon K. Choi2, Chio Yokose1 and Natalie McCormick1, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Lexington, MA

Meeting: ACR Convergence 2024

Keywords: diet, Epidemiology, gout, Inflammation, metabolomics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Epidemiology & Public Health I

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Only 20% of those with hyperuricemia develop clinically evident gout, suggesting that other, likely inflammatory, factors influence NLRP3 inflammasome activation and progression to gout. Prior work has found that a proinflammatory diet is associated with an approximate doubling of female gout risk (between extreme quintiles);1 however, specific mechanisms are unknown. Metabolomics may provide novel insights into the role of metabolites in mediating the associations between a proinflammatory diet and gout. We prospectively examined the relation between three novel plasma metabolomic signatures of inflammation and female gout risk in the Nurses’ Health Study over 26 years.

Methods: We analyzed data from 5,936 women with complete metabolite data who were free of gout at baseline. Diet, covariates, and new cases of physician-diagnosed gout were ascertained by validated questionnaires every 2-4 years. We calculated an empirical dietary inflammatory pattern (EDIP) score2 for all participants, with higher scores reflecting a habitual proinflammatory diet. To evaluate the interplay between the EDIP, plasma metabolome, and gout, we examined 3 novel metabolomic signatures constructed using elastic net regression.3 These 3 signatures included metabolites that were predominantly associated with: (1) the EDIP dietary score, regardless of the metabolites’ association with any inflammatory biomarkers (i.e., EDIP-only signature); (2) a panel of 4 inflammatory biomarkers, regardless of the metabolites’ association with diet (i.e., CRP, IL-6, TNF-α-R2, and adiponectin; biomarker-only signature); and (3) a combination of both the EDIP and 4 biomarkers (i.e., combined signature). We used multivariable Cox models to evaluate the associations between each metabolomic signature and incident gout.

Results: We ascertained 228 cases of incident gout over 26 years. In our multivariable models, women in the highest EDIP quartile (most proinflammatory diet) had 2.04-times (95% CI 1.32, 3.14) greater gout risk compared with the lowest quartile (Table). We observed strong positive associations with gout for the EDIP-only (HR for extreme quartiles 2.20 [1.39, 3.47]) and biomarker-only (2.52 [1.61, 3.92]) metabolomic signatures. Greater scores for the combined signature were associated with the highest gout risk among all 3 signatures (HR for extreme quartiles 2.94 [1.81, 4.80]). The association between the EDIP (dietary intake) and gout was attenuated with further adjustment for each metabolomic signature, although it remained significant (HR for extreme quartiles 1.70 [1.09, 2.67], 1.81 [1.17, 2.80], and 1.83 [1.18, 2.83] after adjusting for the EDIP-only, biomarker-only, and combined signatures, respectively), suggesting diet’s effect on gout may be partly mediated by these metabolomic profiles.

Conclusion: Three novel metabolomic signatures of inflammation were each strongly associated with gout risk, suggesting that both adherence and intrinsic metabolic response to a proinflammatory dietary pattern may modulate gout risk.

References:

  1. McCormick et al. A&R 2021 [abstract]. 
  2. Lee et al. Diabetes Care 2020 [PMID: 32873589].
  3. Lee et al. Diabetologia 2024 [PMID: 37816982].

Supporting image 1


Disclosures: S. Rai: None; H. Choi: Ani, 1, Horizon, 1, 5, LG, 1, Protalix, 1, Shanton, 12, DSMB; C. Yokose: None; N. McCormick: None.

To cite this abstract in AMA style:

Rai S, Choi H, Yokose C, McCormick N. Three Novel Metabolomic Signatures of Inflammation for Female Gout Risk: A Prospective Cohort Study over 26 Years [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/three-novel-metabolomic-signatures-of-inflammation-for-female-gout-risk-a-prospective-cohort-study-over-26-years/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/three-novel-metabolomic-signatures-of-inflammation-for-female-gout-risk-a-prospective-cohort-study-over-26-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology